Cite

HARVARD Citation

    Pierre, S. et al. (2021). Superior Outcomes With Continuing Tenofovir Versus Switching to Zidovudine in Second-Line Antiretroviral Therapy in Haiti. Open forum infectious diseases. p. . [Online]. 
  
Back to record